PMID- 26504179 OWN - NLM STAT- MEDLINE DCOM- 20170512 LR - 20170512 IS - 1468-2079 (Electronic) IS - 0007-1161 (Linking) VI - 100 IP - 7 DP - 2016 Jul TI - Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. PG - 897-901 LID - 10.1136/bjophthalmol-2015-307068 [doi] AB - AIMS: To determine whether there is a significant correlation between the peripapillary retinal thickness (pRT) and the serum level of vascular endothelial growth factor (VEGF) in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome. METHODS: This was a cross-sectional, observational case series. We studied 34 eyes of 17 treatment-naive patients with POEMS syndrome whose intracranial pressure was within the normal range. The spectral-domain optical coherence tomographic (SD-OCT) examinations consisted of circle scans of 3.45 mm diameter around the optic disc. The pRT was automatically measured in the SD-OCT images and was used for the statistical analysis. The serum level of VEGF was measured by ELISAs, and the correlation between the pRT and the serum level of VEGF was determined. Multivariable logistic regression analyses were used to identify independent factors that were correlated with the pRT. RESULTS: There was a significant positive correlation between the serum levels of VEGF and the average pRT of the two eyes of each patient (r=0.81, p<0.0001). There was a significant correlation between the pRT of the right and left eyes with an intraclass correlation coefficient of 0.839. Multiple regression analysis showed that the serum levels of VEGF were independent contributors to the pRT (standard regression coefficient=0.59, p=0.012). CONCLUSIONS: The significant correlation between the pRT and the serum level of VEGF suggests that the higher serum level of VEGF might be associated with the development of the optic disc oedema in patients with POEMS syndrome. CI - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. FAU - Yokouchi, Hirotaka AU - Yokouchi H AD - Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Baba, Takayuki AU - Baba T AD - Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Misawa, Sonoko AU - Misawa S AD - Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Sawai, Setsu AU - Sawai S AD - Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. AD - Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan. AD - Division of Laboratory Medicine and Clinical Genetics, Chiba University Hospital, Chiba, Japan. FAU - Kitahashi, Masayasu AU - Kitahashi M AD - Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Oshitari, Toshiyuki AU - Oshitari T AD - Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Kuwabara, Satoshi AU - Kuwabara S AD - Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Yamamoto, Shuichi AU - Yamamoto S AD - Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. LA - eng PT - Journal Article PT - Observational Study DEP - 20151026 PL - England TA - Br J Ophthalmol JT - The British journal of ophthalmology JID - 0421041 RN - 0 (Biomarkers) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Adult MH - Aged MH - Biomarkers/blood MH - Cross-Sectional Studies MH - Disease Progression MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Intracranial Pressure MH - Male MH - Middle Aged MH - Optic Disk/*diagnostic imaging MH - POEMS Syndrome/blood/complications/*diagnosis MH - Papilledema/blood/diagnosis/*etiology MH - Prognosis MH - Retina/*pathology MH - Tomography, Optical Coherence/*methods MH - Vascular Endothelial Growth Factor A/*blood EDAT- 2015/10/28 06:00 MHDA- 2017/05/13 06:00 CRDT- 2015/10/28 06:00 PHST- 2015/04/23 00:00 [received] PHST- 2015/09/28 00:00 [revised] PHST- 2015/09/29 00:00 [accepted] PHST- 2015/10/28 06:00 [pubmed] PHST- 2017/05/13 06:00 [medline] PHST- 2015/10/28 06:00 [entrez] AID - bjophthalmol-2015-307068 [pii] AID - 10.1136/bjophthalmol-2015-307068 [doi] PST - ppublish SO - Br J Ophthalmol. 2016 Jul;100(7):897-901. doi: 10.1136/bjophthalmol-2015-307068. Epub 2015 Oct 26.